Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$76.11
Price-0.22%
-$0.17
1Y
Price
Market Cap
$112.873b
Large
Price/Earnings 3y Avg5y Avg
39.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+27.0%
EBITDA Margin+14.9%
Net Profit Margin+22.9%
Free Cash Flow Margin+27.0%
EBITDA Margin+14.9%
Net Profit Margin+22.9%
Free Cash Flow MarginRevenue
$19.350b
+15.5%
1y CAGR+15.2%
3y CAGR+13.0%
5y CAGREarnings
$2.788b
+50.4%
1y CAGR+65.0%
3y CAGR+40.5%
5y CAGREPS
$1.86
+48.8%
1y CAGR+67.8%
3y CAGR+42.2%
5y CAGRBook Value
$23.630b
$42.707b
Assets$19.077b
Liabilities$12.046b
DebtDebt to Assets
28.2%
2.4x
Debt to EBITDAFree Cash Flow
$3.775b
+42.7%
1y CAGR+61.5%
3y CAGR+38.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company